Featured Articles

  1. Transform Your Drug Safety Data And Adjudication Processes With Technology 7/6/2021

    Many may not know that cloud platforms can help streamline clinical endpoint adjudication. Read below to see how these play a role in cutting costs, improving data quality, smoothing regulatory approval, and speeding time to market.

  2. How Technology Is Transforming Clinical Endpoint Adjudication 5/6/2021

    Trial sponsors and CROs are turning to clinical endpoint committees (CEC) for independent event adjudication as the most efficient process to help reduce costs, increase quality, and eliminate clinical bias. Some endpoint adjudication processes still use manual procedures to collect critical documents from sites or provide them to the CEC, including using physical mail or email. Read how the right technology gives you control over your timelines and allows you to configure your own trials and can standardize what data is collected and organized.

  3. CRO Challenges And Strategies: COVID-19 And Beyond 4/22/2021

    COVID-19 has challenged the pharma industry like never before. However, clinical research organizations (CROs) and technology providers have partnered to develop innovative solutions that have transformed the drug development industry. In this Q&A, we speak with analysts from IDC Health Insights to learn more about the challenges they are facing and how they are leveraging technology to stay competitive during this pandemic.

  4. Developing A Mobile Sensor Strategy Journey For Better Study Outcomes 4/15/2021

    With the growth of digital health technologies and an increasingly large selection of possible devices, this white paper highlights considerations as sponsors and CROs develop their DHT strategy.

  5. A Guide For Discussing Decentralized Clinical Trials With Your CRO 4/15/2021

    Disruptions preventing or limiting site access to patients, monitors, and CRAs are propelling long-lasting changes in the research industry. The urgency to adapt to evolving requirements for both patients and sites is prompting sponsors to engage in new discussions with their CROs. This guide provides eight parameters to help sponsors optimize their path to virtualization across key site- and patient-centric capabilities.

  6. Artificial Intelligence Can Boost Reliability And Speed Of Medical Imaging Analysis In Clinical Trials 3/29/2021

    Pharmaceutical firms face many challenges in bringing their products through clinical trials — from enrollment delays to data quality issues — and every advantage can make a difference. In image analysis, sponsors can gain a critical advantage by leveraging artificial intelligence (AI) or machine learning (ML) — computer solutions that mimic human intelligence and are continually enhanced and updated to become more accurate as they take in more data.

  7. The Growth Of Phase IV Trials And The Need To Demonstrate Effectiveness Using Electronic Patient Reported Outcomes 7/10/2020

    This paper addresses and describes the growing need to satisfy the value perception of multiple stakeholders and the importance of Late Phase trials capturing Clinical Outcome Assessments (COA) and electronic Patient Reported Outcomes (ePRO) in relation to this.

  8. The Impact Of ADAPTABLE: The Industry's First And Largest Fully Decentralized Clinical Megatrial 7/10/2020

    Web-based application remotely manages the informed consent process, enrollment, and randomization of ADAPTABLE participants while allowing them to easily report their health outcomes throughout the study from the comfort of their homes.